Lataa...
UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome
Half a century ago, Harry Angelman reported three patients with overlapping clinical features, now well known as Angelman syndrome. Angelman syndrome is caused by mutations affecting the maternally inherited UBE3A gene, which encodes an E3‐ubiquitin ligase that is critical for typical postnatal brai...
Tallennettuna:
| Julkaisussa: | Dev Med Child Neurol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8248324/ https://ncbi.nlm.nih.gov/pubmed/33543479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dmcn.14831 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|